A Phase 1 Study Evaluating the Safety of LEO 90105 and Its Vehicle, After Multiple Administration on Intact Skin of Healthy Japanese Male Subjects. A Single Centre, Prospective, Randomised, Double-blinded, Vehicle-controlled Clinical Study
Latest Information Update: 01 Mar 2025
Price :
$35 *
At a glance
- Drugs Betamethasone-dipropionate/calcipotriol (Primary)
- Indications Atopic dermatitis; Psoriasis
- Focus Adverse reactions
- Sponsors LEO Pharma
- 18 Jun 2011 New trial record